Get the Stockscreener App
7.51
1.35%
0.10
After Hours:
7.43
-0.08
-1.07%
Tenax Therapeutics Inc stock is traded at $7.51, with a volume of 65,840.
It is up +1.35% in the last 24 hours and up +22.91% over the past month.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.
See More
Previous Close:
$7.41
Open:
$7.4
24h Volume:
65,840
Relative Volume:
1.05
Market Cap:
$34.26M
Revenue:
-
Net Income/Loss:
$-14.56M
P/E Ratio:
-0.4465
EPS:
-16.82
Net Cash Flow:
$-12.46M
1W Performance:
+0.27%
1M Performance:
+22.91%
6M Performance:
+37.54%
1Y Performance:
+98.15%
1-Day Range:
$7.24
$7.7299
1-Week Range:
$7.24
$8.2438
52-Week Range:
$3.6101
$8.2438
Tenax Therapeutics Inc Stock (TENX) Company Profile
Name
Tenax Therapeutics Inc
Sector
Industry
Phone
919-855-2100
Address
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
7.51 | 33.81M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-08-25 | Initiated | Piper Sandler | Overweight |
| Oct-24-24 | Initiated | Leerink Partners | Outperform |
| Oct-14-24 | Initiated | Guggenheim | Buy |
| Sep-30-24 | Initiated | William Blair | Outperform |
| May-18-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Dec-16-14 | Initiated | MLV & Co | Buy |
| Nov-18-14 | Initiated | WallachBeth | Buy |
View All
Tenax Therapeutics Inc Stock (TENX) Latest News
Will Tenax Therapeutics Inc. stock benefit from infrastructure spendingBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Analyzing drawdowns of Tenax Therapeutics Inc. with statistical toolsQuarterly Risk Review & Expert Verified Movement Alerts - newser.com
Historical volatility pattern of Tenax Therapeutics Inc. visualizedJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
How hedge fund analytics apply to Tenax Therapeutics Inc. stock2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Tenax Therapeutics Inc. stock trend forecast2025 Growth vs Value & Weekly Watchlist for Hot Stocks - newser.com
Is Tenax Therapeutics Inc. stock a dividend growth opportunity2025 Market Outlook & Risk Managed Investment Signals - newser.com
What MACD signals say about Tenax Therapeutics Inc.Long Setup & Fast Exit/Entry Strategy Plans - newser.com
Risk vs reward if holding onto Tenax Therapeutics Inc.2025 Price Action Summary & Consistent Profit Focused Trading Strategies - newser.com
Detecting price anomalies in Tenax Therapeutics Inc. with AIWeekly Volume Report & Free Reliable Trade Execution Plans - newser.com
What moving averages say about Tenax Therapeutics Inc.Day Trade & Free Weekly Watchlist of Top Performers - newser.com
Can you recover from losses in Tenax Therapeutics Inc.Market Rally & Consistent Growth Equity Picks - newser.com
Real time alert setup for Tenax Therapeutics Inc. performanceAnalyst Upgrade & Reliable Intraday Trade Alerts - newser.com
Tenax Therapeutics (NASDAQ:TENX) Stock Crosses Above 200-Day Moving Average – Here’s What Happened - Defense World
Exit strategy if you’re trapped in Tenax Therapeutics Inc.Watch List & Accurate Technical Buy Alerts - newser.com
What drives Mitsubishi Corporation Common Stock MBI1 stock priceRisk Mitigation Techniques & Big Gains Low Cost - earlytimes.in
What drives Tenax Therapeutics Inc stock priceGrowth vs. Value Investing & Market Volatility Strategies - earlytimes.in
Using data models to predict Tenax Therapeutics Inc. stock movementDollar Strength & Reliable Breakout Forecasts - newser.com
Will Tenax Therapeutics Inc. stock benefit from green energy trends2025 Analyst Calls & Low Risk High Reward Ideas - newser.com
We Think Tenax Therapeutics (NASDAQ:TENX) Can Afford To Drive Business Growth - Sahm
Tenax Therapeutics (NASDAQ:TENX) Stock Passes Above 200 Day Moving Average – Here’s Why - Defense World
Tenax Therapeutics Inc Stock (TENX) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):